Try from €1.50 / week
A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC
SHARES in Elan gained almost 20% yesterday after the company said a safety review of its multiple sclerosis drug had shown no new cause for concern.
Wed, 10 Aug, 2005
A class action lawsuit has been taken in the United States against directors of Biogen Idec alleging insider dealing in the shares.
Fri, 04 Mar, 2005
News
Friday, February 13, 2026 - 5:00 PM